Patent: 9,901,623
✉ Email this page to a colleague
Summary for Patent: 9,901,623
Title: | Rapid-acting insulin compositions |
Abstract: | The invention is a pharmaceutical composition of human insulin or insulin analog that includes citrate, treprostinil and stabilizing agents, that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products and that is stable for commercial use. |
Inventor(s): | Akers; Michael Patrick (Indianapolis, IN), Christe; Michael Edward (Pendleton, IN), Hardy; Thomas Andrew (Carmel, IN), Majumdar; Ranajoy (Indianapolis, IN), Nguyen; Chi Arch (Fishers, IN), Paavola; Chad Donald (Carmel, IN), Sarin; Virender Kumar (Carmel, IN), Schulte; Nanette Elizabeth (Indianapolis, IN) |
Assignee: | Eli Lilly and Company (Indianapolis, IN) |
Application Number: | 15/241,412 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,901,623 |
Patent Claims: | see list of patent claims |
Details for Patent 9,901,623
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Eli Lilly And Company | HUMALOG | insulin lispro | Injection | 020563 | 06/14/1996 | ⤷ Try a Trial | 2040-03-31 |
Eli Lilly And Company | HUMALOG | insulin lispro | Injection | 020563 | 08/06/1998 | ⤷ Try a Trial | 2040-03-31 |
Eli Lilly And Company | HUMALOG | insulin lispro | Injection | 020563 | 09/06/2007 | ⤷ Try a Trial | 2040-03-31 |
Eli Lilly And Company | HUMALOG | insulin lispro | Injection | 020563 | 06/06/2017 | ⤷ Try a Trial | 2040-03-31 |
Eli Lilly And Company | HUMALOG | insulin lispro | Injection | 020563 | 11/15/2019 | ⤷ Try a Trial | 2040-03-31 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |